Every product that carries the Wimits name is manufactured under Good Manufacturing Practice (GMP) — the set of controls that govern facilities, equipment, personnel, and processes to ensure consistent quality, safety, and efficacy in every batch.
Wimits Pharmaceuticals (Pvt.) Ltd. is committed to manufacturing pharmaceutical, nutraceutical, and veterinary health products that consistently meet the quality, safety, and efficacy standards required by regulatory authorities and expected by healthcare professionals and patients. We achieve this through continuous investment in our people, our facilities, and our quality management systems — treating compliance not as a checkbox, but as the foundation of every batch we release.
Our manufacturing facility and quality control laboratory operate under the licenses and certifications below, issued by the Government of Pakistan, Acerta Middle East, and the Pakistan National Accreditation Council. Click any certificate to view the full scanned document.
Government of Pakistan, Central Licensing Board — licensed to manufacture drugs registered under the Drugs Act, 1976 by way of Formulation at Plot No. 129, Sundar Industrial Estate, Raiwind Road, Lahore.
Pakistan National Accreditation Council — our Quality Control Laboratory is accredited to ISO/IEC 17025:2015.
Issued by Acerta Middle East for our Quality Management System covering manufacturing of pharmaceutical products by way of formulation, human and veterinary dosage forms.
Issued by Acerta Middle East in recognition of our Environmental Management System across pharmaceutical formulation and veterinary product manufacturing.
Issued by Acerta Middle East in recognition of our Occupational Health and Safety Management System across our manufacturing operations.
Our facility follows a structured, documented approach at every stage of production — from raw material intake to finished-goods release.
Every batch passes through a defined sequence of checks before it's released for distribution.
Incoming materials are quarantined and tested against approved specifications before entering production.
Critical parameters are checked at each manufacturing stage to catch deviations early.
Every batch is tested in our QA/QC lab against pharmacopeial and in-house specifications.
Only batches that pass every check are approved for release and distribution.
Wimits Pharmaceuticals operates under the oversight of the Drug Regulatory Authority of Pakistan (DRAP) and complies with all applicable national pharmaceutical, nutraceutical, and veterinary health regulations. Our products, facilities, and processes are subject to periodic inspection and audit to confirm ongoing GMP compliance. For product-specific registration numbers, certificates of analysis, or regulatory documentation, please contact us.